Ion-pair charge transfer complex with near-IR absorption: Synthesis, crystal structure and properties of [Hb]2[Cu(mnt)2] (Hb = 1-(4-((1H-imidazol-1-yl)methyl)benzyl)-1H-imidazol-3-ium)
-
Add time:08/05/2019 Source:sciencedirect.com
The compound [Hb]2[Cu(mnt)2] (1) [Hb = 1-(4-((1H-imidazol-1-yl)methyl)benzyl)-1H-imidazol-3-ium] has been synthesized, starting from 1,4-bis((1H-imidazol-1-yl)methyl)benzene, cupric chloride, and Na2mnt in methanol. Compound 1 crystallizes in monoclinic system with C2/c space group. In the crystal structure, the interactions between cations and anions via bifurcated CH···(NC-mnt)2 hydrogen bonds give rise to a two dimensional supramolecular network. It has also been observed that two cation moieties (Hb) are attached together by a very short CH···N hydrogen bonding interaction with H···N distance of 1.74 Å, ∠CHN bond angle of 174.9°. Compound 1 is additionally characterized by cyclic voltammetry, UV–Vis, IR, 1H NMR and EPR spectroscopy. The ion-pair compound 1 shows an intense absorption in the near-IR region at ∼1214 nm which has been described as a charge transfer band from HOMO of the copper dithiolate anion [Cu(mnt)2]2−, to LUMO of the [Hb]+ cation. The title compound exhibits an oxidative response at +0.46 V vs. Ag/AgCl and a reductive event at −0.67 V vs. Ag/AgCl.
We also recommend Trading Suppliers and Manufacturers of 1-(1-METHYL-1H-IMIDAZOL-2-YL)-PIPERAZINE (cas 113049-35-7). Pls Click Website Link as below: cas 113049-35-7 suppliers
Prev:Biology-oriented drug synthesis (BIODS) of 2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl aryl ether derivatives, in vitro α-amylase inhibitory activity and in silico studies
Next:Biology-oriented drug synthesis (BIODS): In vitro β-glucuronidase inhibitory and in silico studies on 2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl aryl carboxylate derivatives) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Synthesis of new 5-((2-(substituted phenoxymethyl)-1H-benzo[d]imidazol-1-yl)methyl)-1,3,4-oxadiazole-2-thiol: A novel class of potential antibacterial and antifungal agents08/10/2019
- Copper(II) and zinc(II) as metal-carboxylate coordination complexes based on (1-methyl-1H-benzo[d]imidazol-2-yl) methanol derivative: Synthesis, crystal structure, spectroscopy, DFT calculations and antioxidant activity08/09/2019
- Importance of 5/6-aryl substitution on the pharmacological profile of 4ʹ-((2-propyl-1H-benzo[d]imidazol-1-yl)methyl)-[1,1ʹ-biphenyl]-2-carboxylic acid derived PPARγ agonists08/08/2019
- Synthesis, spectroscopic and DNA binding ability of CoII, NiII, CuII and ZnII complexes of Schiff base ligand (E)-1-(((1H-benzo[d]imidazol-2-yl)methylimino)methyl)naphthalen-2-ol. X-ray crystal structure determination of cobalt (II) complex08/07/2019
- Biology-oriented drug synthesis (BIODS): In vitro β-glucuronidase inhibitory and in silico studies on 2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl aryl carboxylate derivatives08/06/2019
- Biology-oriented drug synthesis (BIODS) of 2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl aryl ether derivatives, in vitro α-amylase inhibitory activity and in silico studies08/04/2019
- Syntheses, crystal structures and luminescent properties of two salts with 2-((1H-imidazol-1-yl)methyl)-1H-benzimidazole08/03/2019


